Blog

Read our latest blog posts on biotech, AI, and funding rare disease research.

March 20, 2025

I recently sat down with a Top 20 pharmaceutical company to discuss their goals and struggles for the year ahead

March 5, 2025

Recently, I had a conversation with Dr. Kanya Rajangam, to discuss current perceptions about Chinese biotech, opportunities, language challenges,

March 3, 2025

Chinese biopharma companies are at an inflection point, with rapidly advancing in science, know-how, + talent. Chinese assets are poised

January 29, 2025

Based on JPM 2025, it’s safe to say that the biotech industry is experiencing a broad resurgence, with subtle yet

January 27, 2025

By combining human expertise with AI-powered analysis, we’re helping biopharma companies make faster, more informed business development decisions.

January 23, 2025

Artificial intelligence-powered pipeline analysis is emerging as a tool that can help teams make better, faster drug development decisions.